Isabelle Bairati

Summary

Affiliation: Laval University
Country: Canada

Publications

  1. ncbi request reprint A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients
    Isabelle Bairati
    Centre de recherche en cancérologie de l Université Laval, Quebec City, Quebec, Canada
    J Natl Cancer Inst 97:481-8. 2005
  2. ncbi request reprint Women's perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer
    I Bairati
    Laval University Cancer Research Center and Direction régionale de Santé Publique de la Capitale nationale, Quebec City, UK
    Eur J Cancer Care (Engl) 15:183-93. 2006
  3. doi request reprint Development and validation of an instrument assessing women's satisfaction with screening mammography in an organized breast cancer screening program
    Isabelle Bairati
    Public Health Agency of the Capitale Nationale, Quebec City, Canada
    BMC Health Serv Res 14:9. 2014
  4. ncbi request reprint Determinants of delay for breast cancer diagnosis
    Isabelle Bairati
    Laval University Cancer Research Center, Canada
    Cancer Detect Prev 31:323-31. 2007
  5. doi request reprint Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
    Bernard Tetu
    Department of Pathology, Centre Hospitalier Universitaire de Quebec, L Hôtel Dieu de Québec, Faculty of Medicine, Laval University Quebec, Quebec City, Quebec, Canada
    Mod Pathol 21:1002-10. 2008
  6. ncbi request reprint Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Nutr Cancer 59:29-35. 2007
  7. ncbi request reprint Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec City, QC, Canada
    Int J Cancer 122:1679-83. 2008
  8. ncbi request reprint Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients
    Isabelle Bairati
    Laval University Cancer Research Center, Quebec City, Quebec, Canada
    Int J Cancer 119:2221-4. 2006
  9. pmc Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec, QC, Canada
    Int J Cancer 128:1741-6. 2011
  10. ncbi request reprint A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Cancer Epidemiol Biomarkers Prev 14:2269-72. 2005

Collaborators

Detail Information

Publications28

  1. ncbi request reprint A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients
    Isabelle Bairati
    Centre de recherche en cancérologie de l Université Laval, Quebec City, Quebec, Canada
    J Natl Cancer Inst 97:481-8. 2005
    ..We assessed whether supplementation with antioxidant vitamins could reduce the incidence of second primary cancers among patients with head and neck cancer...
  2. ncbi request reprint Women's perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer
    I Bairati
    Laval University Cancer Research Center and Direction régionale de Santé Publique de la Capitale nationale, Quebec City, UK
    Eur J Cancer Care (Engl) 15:183-93. 2006
    ..Patients' perceptions, such as those regarding the importance of human intervention in the process of continuity of care, should be taken into account by healthcare authorities in charge of implementing cancer control programmes...
  3. doi request reprint Development and validation of an instrument assessing women's satisfaction with screening mammography in an organized breast cancer screening program
    Isabelle Bairati
    Public Health Agency of the Capitale Nationale, Quebec City, Canada
    BMC Health Serv Res 14:9. 2014
    ..The objective of this study was to develop and validate an instrument in French designed to evaluate the satisfaction of women having a screening mammography...
  4. ncbi request reprint Determinants of delay for breast cancer diagnosis
    Isabelle Bairati
    Laval University Cancer Research Center, Canada
    Cancer Detect Prev 31:323-31. 2007
    ..A study was conducted to identify determinants of diagnostic delay in order to develop strategies to reduce the waiting time for breast cancer diagnosis...
  5. doi request reprint Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
    Bernard Tetu
    Department of Pathology, Centre Hospitalier Universitaire de Quebec, L Hôtel Dieu de Québec, Faculty of Medicine, Laval University Quebec, Quebec City, Quebec, Canada
    Mod Pathol 21:1002-10. 2008
    ..61; CI: 0.94-2.79; P=0.08). Our study shows that gene expression analysis coupled with immunohistochemistry allowed the identification of HSP10 as an independent factor of progression-free survival...
  6. ncbi request reprint Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Nutr Cancer 59:29-35. 2007
    ..This study suggests that a higher usual dietary beta carotene intake can reduce the occurrence of severe adverse effects of radiation therapy and decrease local cancer recurrence...
  7. ncbi request reprint Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec City, QC, Canada
    Int J Cancer 122:1679-83. 2008
    ..Particular attention should be devoted to prevent patients from both smoking and taking antioxidant supplements during radiation therapy...
  8. ncbi request reprint Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients
    Isabelle Bairati
    Laval University Cancer Research Center, Quebec City, Quebec, Canada
    Int J Cancer 119:2221-4. 2006
    ..38, 95% confidence interval 1.03-1.85. Cause-specific mortality rates tended to be higher in the supplement arm than in the placebo arm. Our results concur with previous reports to suggest that high-dose vitamin E could be harmful...
  9. pmc Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients
    Francois Meyer
    Laval University Cancer Research Center, Quebec, QC, Canada
    Int J Cancer 128:1741-6. 2011
    ..Our results contrast with those from most published studies, which suggest prognostic significance of vitamin D status in cancer patients at least in subgroups...
  10. ncbi request reprint A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Cancer Epidemiol Biomarkers Prev 14:2269-72. 2005
    ..Our results are consistent with those of some previous prospective studies and suggest that IGF axis variables are not long-term predictors of the occurrence of prostate cancer...
  11. doi request reprint Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy
    Francois Meyer
    Laval University Cancer Research Center, CHUQ HDQ, Quebec, Canada
    J Clin Oncol 27:2970-6. 2009
    ..To assess the added prognostic value for overall survival (OS) of baseline health-related quality of life (HRQOL) and of early changes in HRQOL among patients with localized head and neck cancer (HNC) treated with radiation therapy...
  12. ncbi request reprint Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Int J Cancer 116:182-6. 2005
    ..54; 95% CI = 0.87-2.72). The supplementation had no effect on PSA or IGF levels. Our findings support the hypothesis that chemoprevention of prostate cancer can be achieved with nutritional doses of antioxidant vitamins and minerals...
  13. doi request reprint Serum prognostic markers in head and neck cancer
    Francois Meyer
    Laval University Cancer Research Center, Quebec, Canada
    Clin Cancer Res 16:1008-15. 2010
    ..We identified from the literature nine potential serum prognostic markers and assessed whether they improve outcome prediction...
  14. ncbi request reprint Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy
    Andre Fortin
    Department of Radiation Oncology, Laval University Cancer Research Center, L Hôtel Dieu de Québec, Quebec City, Quebec, Canada
    Int J Radiat Oncol Biol Phys 52:929-36. 2002
    ..The aim of the present study was to analyze the impact of delaying treatment on the outcome of patients with early head-and-neck squamous cell carcinomas...
  15. ncbi request reprint Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma
    Ari Nareg Meguerditchian
    Department of Surgery, Hôtel Dieu de Québec du Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada
    Am J Surg 189:707-13. 2005
    ..Surgery is considered curative in Dukes' B rectal cancer; however, many patients present with early relapse. To identify additional staging information, venous and lymphatic invasion were evaluated as potential prognostic factors...
  16. ncbi request reprint Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer
    Francois Meyer
    Laval University Cancer Research Center, Quebec City, Quebec, Canada
    Can J Urol 13:3255-60. 2006
    ....
  17. doi request reprint Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer
    Alice Nourissat
    Clinical Epidemiology Unit, Laval University Cancer Research Center, Chuq Hotel Dieu de Quebec, Quebec City, Quebec, Canada
    Cancer 116:2275-83. 2010
    ..The purpose of the study was to identify predictors of weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer...
  18. doi request reprint Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer
    Melanie K Sackett
    Pathology Department, Centre Hospitalier Universitaire de Québec and Université Laval, Quebec, Canada
    Clin Cancer Res 14:67-73. 2008
    ..However, the role of COX-2 overexpression in head and neck cancers remains undetermined. The objective of this study was to evaluate whether COX-2 is a prognostic factor in glottic cancer...
  19. ncbi request reprint p53 and Ki-67 as markers of radioresistance in head and neck carcinoma
    Christian Couture
    Service de Pathologie, CHUQ, L Hôtel Dieu de Québec, Quebec, Canada
    Cancer 94:713-22. 2002
    ..p53 and Ki-67 are regarded as potential interesting predictors of radioresistance, although their exact influence awaits confirmation on a large cohort of uniformly treated patients...
  20. pmc PSA screening and prostate cancer mortality
    Linda Perron
    Centre de recherche en cancérologie de l Université Laval, Departement de Medecine sociale et preventive, Faculte de Medecine, Universite Laval, Quebec City, Que
    CMAJ 166:586-91. 2002
    ..In order to test this hypothesis, we assessed the relation between the change in prostate cancer incidence in the early 1990s, attributed largely to PSA screening, and the subsequent change in prostate cancer mortality...
  21. ncbi request reprint Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
    Linda Perron
    Centre de Recherche en Cancerologie, Universite Laval, CHUQ, Hotel Dieu de Quebec, 11 Cote du Palais, Quebec, Canada G1R 2J6
    Int J Cancer 106:409-15. 2003
    ..The results suggest that long-term and regular use of aspirin, at a dosage beneath that usually recommended for an anti-inflammatory effect, may prevent prostate cancer...
  22. ncbi request reprint Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients
    Isabelle Bairati
    Laval University Cancer Research Center, CHUQ HDQ, 11, Cote du Palais, Quebec, G1R 2J6 Canada
    J Clin Oncol 23:5805-13. 2005
    ....
  23. ncbi request reprint Antihypertensive drug use and the risk of prostate cancer (Canada)
    Linda Perron
    Centre de recherche en cancérologie de l Université Laval, Canada
    Cancer Causes Control 15:535-41. 2004
    ..To verify if exposure to antihypertensive drugs was associated to prostate cancer (PC) risk...
  24. pmc Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies
    Andrew W Roddam
    Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF, United Kingdom
    Ann Intern Med 149:461-71, W83-8. 2008
    ..Some, but not all, published results have shown an association between circulating blood levels of some insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) and the subsequent risk for prostate cancer...
  25. doi request reprint Genetic polymorphisms and head and neck cancer outcomes: a review
    Jessica Hopkins
    Community Medicine Residency Program and Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada
    Cancer Epidemiol Biomarkers Prev 17:490-9. 2008
    ..Despite a large number of exploratory studies, large replication studies in well-characterized HNC populations are warranted...
  26. doi request reprint Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer
    Martine Perigny
    Department of Pathology, Centre Hospitalier Universitaire de Quebec, L Hôtel Dieu de Québec, Canada
    Am J Clin Pathol 129:226-31. 2008
    ....
  27. ncbi request reprint A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique
    Sylvie Vass
    Department of Radio Oncology, Complexe Hospitalier de la Sagamie, Chicoutimi, Quebec, Canada
    Int J Radiat Oncol Biol Phys 62:1274-82. 2005
    ..To compare cosmetic results of two different radiotherapy (RT) boost techniques used in the treatment of breast cancer after whole breast radiotherapy and to identify factors affecting cosmetic outcomes...
  28. ncbi request reprint Implementing the role of patient-navigator nurse at a university hospital centre
    Lise Fillion
    Faculte des sciences infirmieres, Universite Laval, Quebec City, QC
    Can Oncol Nurs J 16:11-7, 5-10. 2006
    ..Several recommendations are formulated, one being the importance of situating the implementation process from an organizational change perspective...